Maravai Lifesciences Holdings (MRVI) Intangibles (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Intangibles of $144.9 million in Q1 2026, down 4.39% quarter-over-quarter from $151.5 million in Q4 2025, and down 27.4% on a YoY basis from $199.6 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Intangibles (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Intangibles history runs 7 years deep, the most recent figure standing at $144.9 million for Q1 2026.
- In Q1 2026, Intangibles fell 27.4% year-over-year to $144.9 million; the TTM figure through Mar 2026 stood at $144.9 million (down 27.4% YoY), while the FY2025 annual figure was $151.5 million, down 22.27% from the prior year.
- Intangibles was $144.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $151.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $241.6 million in Q1 2023 to a low of $144.9 million in Q1 2026.
- Historically, Intangibles has averaged $207.2 million across 5 years, with a median of $214.1 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Intangibles surged 84.28% in 2022, then slipped 27.4% in 2026.
- A 5-year view of Intangibles shows it stood at $216.7 million in 2022, then gained by 2.0% to $221.0 million in 2023, then retreated by 11.78% to $195.0 million in 2024, then dropped by 22.27% to $151.5 million in 2025, then dropped by 4.39% to $144.9 million in 2026.
- The last three Intangibles figures came in at $144.9 million (Q1 2026), $151.5 million (Q4 2025), and $185.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 7.73 Mn |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 144.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.89 Mn |
| Dec 31, 2025 | 151.54 Mn |
| Sep 30, 2025 | 185.88 Mn |
| Jun 30, 2025 | 193.07 Mn |
| Mar 31, 2025 | 199.58 Mn |
| Dec 31, 2024 | 194.96 Mn |
| Sep 30, 2024 | 201.86 Mn |
| Jun 30, 2024 | 207.25 Mn |
| Mar 31, 2024 | 214.12 Mn |
| Dec 31, 2023 | 220.99 Mn |
| Sep 30, 2023 | 227.86 Mn |
| Jun 30, 2023 | 234.73 Mn |
| Mar 31, 2023 | 241.58 Mn |
| Dec 31, 2022 | 216.66 Mn |
| Sep 30, 2022 | 222.90 Mn |
| Jun 30, 2022 | 229.15 Mn |
| Mar 31, 2022 | 235.41 Mn |
| Dec 31, 2021 | 117.57 Mn |
| Sep 30, 2021 | 121.23 Mn |
| Jun 30, 2021 | 125.12 Mn |